Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice

BACKGROUND: Interleukin-16 (IL-16) is an important inflammatory regulator and has been shown to have a powerful effect on the regulation of the inflammatory response. Cardiac inflammation has been reported to be closely related to doxorubicin- (DOX-) induced cardiac injury. In this study, the role o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mediators Inflamm
Autors principals: Zhang, Jianwei, Yang, Zicong, Liang, Zhishan, Wang, Mengjie, Hu, Changxing, Chang, Chao, Shi, Lei, Ji, Qingwei, Liu, Ling
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8075660/
https://ncbi.nlm.nih.gov/pubmed/33958974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6611085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars